rubidium has been researched along with dihydro-beta-erythroidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, DJ; Brioni, JD; Decker, MW; Donnelly-Roberts, DL; Kang, CH; O'Neill, AB; Piattoni-Kaplan, M; Sullivan, JP; Swanson, S | 1 |
Bullock, AE; Calcaterra, J; Changeux, JP; Collins, AC; Grady, SR; Marks, MJ; Picciotto, MR; Stitzel, JA; Whiteaker, P | 1 |
Crooks, PA; Dwoskin, LP; Pauly, JR; Wilkins, LH | 1 |
3 other study(ies) available for rubidium and dihydro-beta-erythroidine
Article | Year |
---|---|
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Binding, Competitive; Corpus Striatum; Dihydro-beta-Erythroidine; Dopamine; Locomotion; Male; Mice; Mice, Inbred Strains; Muscles; Neuroblastoma; Neurons; Nicotinic Antagonists; Quinolizines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Rubidium; Rubidium Radioisotopes; Temperature; Tritium; Tumor Cells, Cultured | 1995 |
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.
Topics: Acetylcholine; Animals; Brain; Bungarotoxins; Dihydro-beta-Erythroidine; In Vitro Techniques; Ligands; Mice; Mice, Inbred BALB C; Mutation; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Rubidium; Rubidium Radioisotopes; Synaptosomes | 1999 |
Development of a novel class of subtype-selective nicotinic receptor antagonist: pyridine-N-substituted nicotine analogs.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Corpus Striatum; Dihydro-beta-Erythroidine; Dopamine; Nicotine; Nicotinic Antagonists; Pyridines; Rats; Receptors, Nicotinic; Rubidium; Synaptosomes | 1999 |